Clinical Trial

Acetic Acid 2% Solution for Skin Ulcers

Study acronym: ECA-AA
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The objective of this clinical trial is to assess the effectiveness of acetic acid in patients suffering from chronic cutaneous ulcers with biofilm. The primary question it seeks to address is whether acetic acid (as a 2% topical solution) is superior to the current standard treatment for chronic cutaneous ulcers with biofilm at our center (Prontosan®). Participants will be randomly assigned to receive either the acetic acid solution treatment or the standard current treatment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-02-29; most recent amendment 2025-06-23.
Status change: Not Yet Recruiting → Recruiting 2025-06-23
Trial Details
NCT Number NCT06297967
Lead Sponsor Consorci Sanitari de l'Alt Penedès i Garraf
Conditions Ulcer, Skin
Enrollment 104 participants
Start Date 2025-04-27
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-06-26